drugset / Trial / NCT03475719
A Clinical Trial to Evaluate the Safety and Pharmacokinetic
RandomizedCrossoverOpen-labelTreatment
Summary
A phase 1 clinical trail to evaluate the safety and pharmacokinetic characteristic after administration of fixed-dose combination or loose combination of HUG186 in healthy adult male or menopausal female volunteers
Timeline
- Start
- 2018-01-11
- Primary completion
- 2018-02-11
- Completion
- 2018-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bazedoxifene | Other / unclassified | 22.6 mg | — |
| Comparator | Cholecalciferol | Other / unclassified | 8 mg | — |